All In MedTech

FDA Clearance Tracker · P130017-S057

COLOGUARD

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 20, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P130017-S057
Device name
COLOGUARD
Applicant location
Medison, WI
Received
Jan 26, 2024
Decided
Jul 20, 2024
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P130017

Device type

Device class
Class III

Every decision under product code PHP

FDA's approval statement

As written in FDA's record.

Approval for updating Cologuard labeling to include the completed Post-Approval study information.

Source documents

Other decisions for Exact Sciences Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.